Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography

Clinical Research in Cardiology

Volumn 103, Issue 3, 2014, Pages 223-227

  Arbel, Yaron ^a   Zlotnik, Margalit ^a   Halkin, Amir ^a   Havakuk, Ofer ^a   Berliner, Shlomo ^a   Herz, Itzhak ^a   Rabinovich, Itay ^a   Keren, Gad ^a   Bazan, Shmuel ^a   Finkelstein, Ariel ^a   Banai, Shmuel ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Admission glucose; Cardiovascular disease; Fasting glucose; HbA1c levels

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART INFARCTION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ORAL GLUCOSE TOLERANCE TEST; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; SYNTAX SCORE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, STABLE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISRAEL; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84897023207     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0641-7     Document Type: Article

References (32)

1. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M (2008) Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 31(Suppl 2):S155-S160
2. Giugliano D, Ceriello A, Esposito K (2008) Glucose metabolism and hyperglycemia. Am J Clin Nutr 87:217S-222S
3. Peter P, Nuttall SL, Kendall MJ (2003) Insulin resistance - the new goal! J Clin Pharm Ther 28:167-174 (Pubitemid 36783092)
4. Farhan S, Jarai R, Tentzeris I, Kautzky-Willer A, Samaha E, Smetana P, Jakl-Kotauschek G, Wojta J, Huber K (2012) Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol 101:625-630
5. De Caterina R, Madonna R, Sourij H, Wascher T (2010) Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options. Eur Heart J 31:1557-1564
6. Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I, Mashav N, Thurm T, Keren G, Finkelstein A (2012) Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc 52:5-14
7. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, Shevach A, Berliner S, Herz I, Keren G (2012) Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 225(2):456-460
8. Arbel Y, Banai S, Benhorin J, Finkelstein A, Herz I, Halkin A, Keren G, Yedgar S, Barashtein G, Berliner S (2012) Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol 154:322-327
9. Arbel Y, Halkin A, Finkelstein A, Revivo M, Berliner S, Herz I, Keren G, Banai S (2013) Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol 29(11):1374-1381
10. Ringqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, Passamani E, Russell RO Jr, Alderman EL, Kouchoukas NT, Kaiser GC, Ryan TJ, Killip T, Fray D (1983) Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 71:1854-1866 (Pubitemid 13056789)
11. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219-227
12. Sadhu AR, Ang AC, Ingram-Drake LA, Martinez DS, Hsueh WA, Ettner SL (2008) Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project. Diabetes Care 31:1556-1561
13. Verges B, Zeller M, Dentan G, Beer JC, Laurent Y, Janin-Manificat L, Makki H, Wolf JE, Cottin Y (2007) Impact of fasting glycemia on short-term prognosis after acute myocardial infarction. J Clin Endocrinol Metab 92:2136-2140 (Pubitemid 46997112)
14. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111:754-760 (Pubitemid 40250636)
15. Kolman L, Hu YC, Montgomery DG, Gordon K, Eagle KA, Jackson EA (2009) Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome. Am J Cardiol 104:470-474
16. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, Sabin GV, Bruder O (2011) Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol 100:649-659
17. Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D (2010) Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol 99:715-721
18. Yang Z, Laubach VE, French BA, Kron IL (2009) Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 137:723-729
19. Ceriello A (2008) Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diabet Vasc Dis Res 5:260-268
20. Zarich SW, Nesto RW (2007) Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 115:e436-e439 (Pubitemid 46717968)
21. Bauters C, Ennezat PV, Tricot O, Lauwerier B, Lallemant R, Saadouni H, Quandalle P, Jaboureck O, Lamblin N, Le Tourneau T (2007) Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J 28:546-552 (Pubitemid 47355520)
22. Yosefy C (2003) Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved? Acta Diabetol 40(Suppl 2):S380-S388
23. Akalin A, Temiz G, Akcar N, Sensoy B (2008) Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes. Endocr J 55(5):861-866
24. Timmer JR, Ottervanger JP, Bilo HJ, Dambrink JH, Miedema K, Hoorntje JC, Zijlstra F (2006) Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM: Mon J Assoc Physicians 99:237-243
25. Karabulut A, Iltumur K, Toprak N, Tuzcu AK, Kara IH, Kaplan A, Aksu Y (2005) Insulin response to oral glucose loading and coronary artery disease in nondiabetics. Int Heart J 46:761-770
26. Geisler T, Mueller K, Aichele S, Bigalke B, Stellos K, Htun P, Ninci E, Fateh-Moghadam S, May AE, Gawaz M (2010) Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions. Clin Res Cardiol 99:743-752
27. Hartge MM, Unger T, Kintscher U (2007) The endothelium and vascular inflammation in diabetes. Diabet Vasc Dis Res 4:84-88 (Pubitemid 47167491)
28. Oswald GA, Yudkin JS (1987) Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med 4:68-70 (Pubitemid 17226937)
29. Ilany J, Marai I, Cohen O, Matetzky S, Gorfine M, Erez I, Hod H, Karasik A (2009) Glucose homeostasis abnormalities in cardiac intensive care unit patients. Acta Diabetol 46:209-216
30. Anantharaman R, Heatley M, Weston CF (2009) Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? Heart 95:697-703
31. Undas A, Wiek I, Stepien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590-1595
32. Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt PR (2007) Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 154:470-476 (Pubitemid 47268241)